Refine
Year of publication
Document Type
- Preprint (665)
- Article (436)
- Working Paper (3)
- Conference Proceeding (1)
Has Fulltext
- yes (1105)
Is part of the Bibliography
- no (1105) (remove)
Keywords
- Heavy Ion Experiments (20)
- Hadron-Hadron Scattering (11)
- Hadron-Hadron scattering (experiments) (11)
- LHC (9)
- Heavy-ion collision (6)
- ALICE experiment (4)
- Collective Flow (4)
- Jets (4)
- Quark-Gluon Plasma (4)
- ALICE (3)
- Epilepsy (3)
- Heavy Ions (3)
- Jets and Jet Substructure (3)
- Seizure (3)
- portal hypertension (3)
- pp collisions (3)
- Beauty production (2)
- Charm physics (2)
- Costs (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- Heavy Quark Production (2)
- Lepton-Nucleon Scattering (experiments) (2)
- Particle Correlations and Fluctuations (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Pb–Pb collisions (2)
- QCD (2)
- Single electrons (2)
- 900 GeV (1)
- ADGRE1 (1)
- ALICE detector (1)
- Angiomyolipoma (1)
- Anti-nuclei (1)
- Anti-seizure medication (1)
- Anticonvulsant (1)
- Autofreies Wohnen (1)
- Autologous stem cell transplantation (1)
- Autoreduziertes Wohnen (1)
- Boosted Jets (1)
- CD36 (1)
- CHRNA10 (1)
- CHRNA7 (1)
- CHRNA9 (1)
- CVID (1)
- Centrality Class (1)
- Centrality Selection (1)
- Collective Flow, (1)
- Comparison with QCD (1)
- Darmstadt (1)
- Depression (1)
- EMR1 (1)
- Elastic scattering (1)
- Electron-pion identification (1)
- Electroweak interaction (1)
- Elliptic flow (1)
- European Society for Immunodeficiencies (ESID) (1)
- Everolimus (1)
- F4/80 (1)
- Fc receptor (1)
- Femtoscopy (1)
- Fibre/foam sandwich radiator (1)
- GWAS (1)
- Genetics (1)
- German PID-NET registry (1)
- HBT (1)
- Hadron production (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Hard Scattering (1)
- Heavy Ion Experiment (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy ions (1)
- Heavy-flavour decay muons (1)
- Heavy-flavour production (1)
- Heavy-ion collisions (1)
- High-dose chemotherapy (1)
- IgG substitution therapy (1)
- Inclusive spectra (1)
- Influenza (1)
- Intensity interferometry (1)
- Invariant Mass Distribution (1)
- Ionisation energy loss (1)
- Jet Physics (1)
- Jet Substructure (1)
- Leishmania infantum (1)
- Lenalidomide (1)
- Lincoln-Siedlung (1)
- MTOR inhibitor (1)
- Material budget (1)
- Mechanisms of disease (1)
- Mid-rapidity (1)
- Minimum Bias (1)
- Mittelhochdeutsch (1)
- Mobilitätskonzept (1)
- Mobilitätsverhalten (1)
- Molecular medicine (1)
- Monte Carlo (1)
- Multi-Parton Interactions (1)
- Multi-strange baryons (1)
- Multi-wire proportional drift chamber (1)
- Multiple myeloma (1)
- NAFLD (1)
- Neural network (1)
- Nuclear modification factor (1)
- P2X7 receptor (1)
- PDE‐5‐inhibitor (1)
- PID prevalence (1)
- PYTHIA (1)
- Parainfluenza (1)
- Particle and Resonance Production (1)
- Pb isotopes (1)
- Pb–Pb (1)
- Pneumonia (1)
- Polarization (1)
- Production Cross Section (1)
- Properties of Hadrons (1)
- Proton–proton (1)
- Quality of life (1)
- Quark Deconfinement (1)
- Quark Gluon Plasma (1)
- Quark Production (1)
- Quark gluon plasma (1)
- Quarkonium (1)
- Rapidity Range (1)
- Relapse (1)
- Relativistic heavy ion physics (1)
- Relativistic heavy-ion collisions (1)
- Resolution Parameter (1)
- Respiratory syncytial virus (1)
- Rhabdomyoma (1)
- Rome (1)
- Second Punic War (1)
- Second-line treatment (1)
- Single muons (1)
- Single-molecule biophysics (1)
- Sociodemographic characteristics (1)
- Subependymal giant cell astrocytoma (1)
- Super-resolution microscopy (1)
- Superinfection (1)
- Systematic Uncertainty (1)
- TGR(mREN2)27 (1)
- TR (1)
- TSC (1)
- Time Projection Chamber (1)
- Tracking (1)
- Transition radiation detector (1)
- Transverse momentum (1)
- Trigger (1)
- Upper respiratory tract infection (1)
- Vector Boson Production (1)
- Western Mediterranean (1)
- Western diet (1)
- Wohnumzug (1)
- Wortfamilie (1)
- Xenon-based gas mixture (1)
- acarboxyprothrombin (1)
- age-related macular degeneration (1)
- alpha-fetoprotein (1)
- angiogenesis (1)
- angiopoietin-2 (1)
- antiepileptic drugs (1)
- biorelevant media (1)
- calcium-independent phospholipase A2β (1)
- cirrhosis (1)
- dE/dx (1)
- detector (1)
- diagnosis (1)
- dissolution (1)
- erectile dysfunction (1)
- experimental results (1)
- genetic generalized epilepsy (1)
- heavy ion experiments (1)
- hepatic stellate cells (1)
- hepatocellular cancer (1)
- hepatocellular carcinoma (1)
- immunity (1)
- immunofluorescence (1)
- immunomodulation (1)
- in vitro models (1)
- inflammasome (1)
- interleukin-1β (1)
- lamotrigine (1)
- levetiracetam (1)
- liver fibrosis (1)
- mTOR inhibitor (1)
- macrophage (1)
- non‐selective beta‐blocker (1)
- pharmacoresistance (1)
- phosphorylcholine (1)
- poorly soluble drugs (1)
- primary immunodeficiency (PID) (1)
- promastigote (1)
- proteomics (1)
- prothrombin induced by vitamin K absence-II (1)
- quark gluon plasma (1)
- registry for primary immunodeficiency (1)
- renin-angiotensin system (1)
- silver coinage (1)
- simplified media (1)
- spectra (1)
- steatosis (1)
- surfactants (1)
- trace elements (1)
- valproic acid (1)
- vascular endothelial growth factor (1)
- √sN N = 2.76 TeV (1)
- fibrogenesis (1)
Institute
- Physik (1068)
- Frankfurt Institute for Advanced Studies (FIAS) (955)
- Informatik (920)
- Medizin (24)
- Geowissenschaften (4)
- Informatik und Mathematik (3)
- Pharmazie (3)
- Hochschulrechenzentrum (2)
- Biochemie und Chemie (1)
- Center for Financial Studies (CFS) (1)
Explosive volcanism affects weather and climate. Primary volcanic ash particles which act as ice nuclei (IN) can modify the phase and properties of cold tropospheric clouds. During the Eyjafjallajökull volcanic eruption we have measured the highest ice nucleus number concentrations (>600 L) in our record of 2 years of daily IN measurements in central Germany. Even in Israel, located about 5000 km away from Iceland, IN were as high as otherwise only during desert dust storms. These measurements are the only ones available on the properties of IN in the Eyjafjallajökull plume. The measured high concentrations and high activation temperature (−8 °C) point to an important impact of volcanic ash on microphysical and radiative properties of clouds through enhanced glaciation.
Genetic generalised epilepsy (GGE) is the most common form of genetic epilepsy, accounting for 20% of all epilepsies. Genomic copy number variations (CNVs) constitute important genetic risk factors of common GGE syndromes. In our present genome-wide burden analysis, large (≥ 400 kb) and rare (< 1%) autosomal microdeletions with high calling confidence (≥ 200 markers) were assessed by the Affymetrix SNP 6.0 array in European case-control cohorts of 1,366 GGE patients and 5,234 ancestry-matched controls. We aimed to: 1) assess the microdeletion burden in common GGE syndromes, 2) estimate the relative contribution of recurrent microdeletions at genomic rearrangement hotspots and non-recurrent microdeletions, and 3) identify potential candidate genes for GGE. We found a significant excess of microdeletions in 7.3% of GGE patients compared to 4.0% in controls (P = 1.8 x 10-7; OR = 1.9). Recurrent microdeletions at seven known genomic hotspots accounted for 36.9% of all microdeletions identified in the GGE cohort and showed a 7.5-fold increased burden (P = 2.6 x 10-17) relative to controls. Microdeletions affecting either a gene previously implicated in neurodevelopmental disorders (P = 8.0 x 10-18, OR = 4.6) or an evolutionarily conserved brain-expressed gene related to autism spectrum disorder (P = 1.3 x 10-12, OR = 4.1) were significantly enriched in the GGE patients. Microdeletions found only in GGE patients harboured a high proportion of genes previously associated with epilepsy and neuropsychiatric disorders (NRXN1, RBFOX1, PCDH7, KCNA2, EPM2A, RORB, PLCB1). Our results demonstrate that the significantly increased burden of large and rare microdeletions in GGE patients is largely confined to recurrent hotspot microdeletions and microdeletions affecting neurodevelopmental genes, suggesting a strong impact of fundamental neurodevelopmental processes in the pathogenesis of common GGE syndromes.
Background and Aims: Prothrombin induced by vitamin K absence-II (PIVKA-II) is a serum biomarker linked to hepatocellular carcinoma (HCC), showing superiority to alpha-fetoprotein (AFP) for early disease detection. We aimed to assess the clinical and analytical performance of the Elecsys® PIVKA-II immunoassay in diagnosing HCC and evaluate PIVKA-II's technical performance.
Methods: Serum samples from adult cases (i.e. patients with a first-time HCC diagnosis; n = 168) and disease controls (i.e. patients without HCC with an at-risk condition; n = 208) were assessed. An AFP cut-off of 20 ng/mL was used to differentiate between HCC cases and disease controls. Clinical performance of the Elecsys PIVKA-II assay was compared with that of comparator assays (Lumipulse G PIVKA-II, μTASWako DCP, ARCHITECT PIVKA-II) using receiver operating characteristic curve analysis to determine the area under the curve (AUC) values.
Results: The Elecsys PIVKA-II assay compared favorably with comparator assays. Using a 28.4 ng/mL cut-off, the Elecsys PIVKA-II assay detected HCC with 86.9% sensitivity and 83.7% specificity. Clinical performance of the Elecsys PIVKA-II assay (AUC: 90.8%) was equivalent to that of comparator assays (AUC: 88.3–89.6%). Relatively high PIVKA-II concentrations were observed for cholangiocarcinoma and pancreatic cancer with the Elecsys assay in specificity panel analyses, indicating that high PIVKA-II concentrations should not be used alone in the absence of other clinical data.
Conclusions: The Elecsys PIVKA-II assay showed good analytical performance under routine laboratory conditions, comparing favorably with comparator assays. These findings support the suitability of the Elecsys PIVKA-II assay as an aid in HCC diagnosis.